The report for Global Precision Medicine Market of Market Research Future comprises
extensive primary research along with the detailed analysis of qualitative as well as
quantitative aspects by various industry experts, key opinion leaders to gain the deeper
insight of the market and industry performance.
Market Scenario:
Precision medicine refers to medicines developed as per an individual’s genetic profile that
helps as a guide for the prevention, diagnosis and treatment of diseases. The Global
Precision Medicine Market was valued at $38.92 billion in 2015, and is expected to
reach $88.64 billion by 2022. Thus the market is expected to perform a growth at a CAGR
of 12.48% from 2015 to 2022.
The major market driving factor for precision medicine are patient’s involvement in personal
healthcare, integration of wireless technologies with portable healthcare devices, and
increase in genetic diseases (due to mutation, UV rays) among others.
The market constraints include potential threat to personal data, high diagnostic cost as a
barrier, potential risk of hardware or software failure, stringent regulations and standards,
lack of awareness about the possible applications of precision medicine, reimbursement
policies and regulatory framework, limited knowledge about the application of test and
techniques, lack of research and evidences creating hindrances in its application.
Key Finding:
The global precision medicine market is expected to reach USD 88.64 billion by
2022.
By ecosystem diagnostic tool companies holds the largest market share of precision
medicine market and is expected to reach USD 27.56 billion by 2022.
By sub-market, company diagnostics holds the largest market share of precision
medicine market and is expected to reach USD 21.32 billion by 2022.
Get Sample copy @ https://www.marketresearchfuture.com/sample_request/925 .
Key Players for Global Precision Medicine Market:
Abbott Laboratories, Almac Group, Ltd., Asuragen, Inc., Biomérieux Sa, Cepheid Inc., Cetics
Healthcare Technologies Gmbh, Ge Healthcare, Glaxosmithkline Plc, Johnson & Johnson,
Laboratory Corporation Of America Holdings, Medtronic, Novartis, Pfizer Inc., Qiagen,
Biobase Gmbh, Quest Diagnostics Inc, Randox Laboratories Ltd., Sanofi Pharma, Takeda
Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Ab-Biotics Sa, Caris
Life Sciences, Healthcore, Inc., Ibm, Innventis, Intel Corporation, Molecular Health Gmbh,
Precision For Medicine
Segments:
Global Precision Medicine Market has been segmented on the basis of ecosystem, sub-
market, therapeutics and region.
Regional Analysis of Global Precision Medicine Market:
Globally North America is the largest market for global precision medicine. Europe is the
second-largest market for global precision medicine. The near future market for precision